Table 1.

Participant characteristics

n	86
Age (yrs)	56 ± 1
Female, n (%)	52 (60)
Prediabetes, n (%)	50 (58)
Body Mass Index (kg/m2)	36.7 ± 0.5
Clinic Systolic Blood Pressure (mmHg)	128 ± 2
Clinic Diastolic Blood Pressure (mmHg)	73 ± 1
24 hr ABPM Daytime SBP (mmHg)	126 ± 1
24 hr ABPM Nocturnal SBP (mmHg)	114 ± 1
Antihypertensive Medication, n (%)	60 (70)
Lipid-lowering Medication, n (%)	31, 36
Nocturnal Systolic BP Dipping (%)	−10 ± 1
Carotid-Femoral PWV (m/s)	9.2 ± 0.2
Hemoglobin A1c (%)	5.7 ± 0.4
C-reactive Protein (mg/L)	4.0 ± 0.4
Total Cholesterol (mg/dL)	197 ± 4
LDL-C (mg/dL)	116 ± 4
HDL-C (mg/dL)	55 ± 2
Triglycerides (mg/dL)	142 ± 7
Insulin (mcU/ml)	15 ± 1
Fasting Glucose (mg/dL)	97 ± 1
HOMA-IR	3.6 ± 0.2
High Risk of OSA, n. (%)	29 (34)

Data are Mean ± SE or n (%). ABPM, ambulatory blood pressure monitoring; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HOMA-IR, homeostatic model of insulin resistance; OSA, obstructive sleep apnea.